Related Experiment Video
Updated: Oct 2, 2025

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
Quang Tuan Rémy Nguyen1,2,3, Juan Dario Ortigoza Escobar4,5, Jean-Marc Burgunder5,6
1AP-HP, Hôpital Henri Mondor-Albert Chenevier, Centre National de Référence Maladie de Huntington, Service de Neurologie, Créteil, France.
Insights
Diagnosing Huntington's disease phenocopies, patients with similar symptoms but no HTT gene mutation, remains difficult. This study proposes a new diagnostic approach integrating clinical red flags and categorized paraclinical tests for improved accuracy.
Area of Science:
- Neurology
- Genetics
- Rare Diseases
Background:
- Huntington's disease (HD) phenocopies present with HD-like symptoms but lack the causative Huntington (HTT) gene mutation.
- Accurate diagnosis of HD phenocopies is challenging, impacting patient management and research.
Purpose of the Study:
- To develop and propose a structured diagnostic approach for identifying Huntington's disease phenocopies.
- To integrate clinical expertise and literature review for improved diagnostic strategies.
Main Methods:
- A comprehensive literature review (1993-2020) on chorea and HD-like disorders.
- Two sequential surveys of movement disorder experts to identify clinical red flags and classify paraclinical tests.
- Application of clustering algorithms (including DBSCAN) for paraclinical test categorization.
- Inclusion of expert recommendations from the European Reference Network-Rare Neurological Diseases (ERN-RND).
Main Results:
- Identified key clinical red flags suggestive of specific differential diagnoses.
- Classified paraclinical tests into tiered recommendations (1st, 2nd, and 3rd-line) based on diagnostic utility.
- Developed a systematic approach combining clinical and paraclinical data.
Conclusions:
- The proposed diagnostic guidance enhances the identification of Huntington's disease phenocopies.
- Integrating clinical red flags with a tiered paraclinical testing strategy improves diagnostic accuracy for challenging cases.
Abstract:
One percent of patients with a Huntington's disease (HD) phenotype do not have the Huntington (HTT) gene mutation. These are known as HD phenocopies. Their diagnosis is still a challenge. Our objective is to provide a diagnostic approach to HD phenocopies based on medical expertise and a review of the literature. We employed two complementary approaches sequentially: a review of the literature and two surveys analyzing the daily clinical practice of physicians who are experts in movement disorders. The review of the literature was conducted from 1993 to 2020, by extracting articles about chorea or HD-like disorders from the database Pubmed, yielding 51 articles, and analyzing 20 articles in depth to establish the surveys. Twenty-eight physicians responded to the first survey exploring the red flags suggestive of specific disease entities. Thirty-three physicians completed the second survey which asked for the classification of paraclinical tests according to their diagnostic significance. The analysis of the results of the second survey used four different clustering algorithms and the density-based clustering algorithm DBSCAN to classify the paraclinical tests into 1st, 2nd, and 3rd-line recommendations. In addition, we included suggestions from members of the European Reference Network-Rare Neurological Diseases (ERN-RND Chorea & Huntington disease group). Finally, we propose guidance that integrate the detection of clinical red flags with a classification of paraclinical testing options to improve the diagnosis of HD phenocopies.
More Related Videos
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Case Studies